What role does albumin play in paclitaxel's transport in the body?

How does albumin affect paclitaxel transport in the bloodstream?

Albumin is one of the main proteins that paclitaxel uses to travel through the bloodstream. After intravenous administration, paclitaxel binds to albumin and is transported largely via albumin-associated complexes rather than as fully free drug. This binding helps determine how much drug remains in circulation and how efficiently it can reach tissues [1].

Why does albumin binding matter for paclitaxel’s delivery to tissues?

Albumin binding influences paclitaxel’s distribution because albumin-associated drug can use albumin’s established transport pathways. In practice, that means albumin-bound paclitaxel is more likely to reach peripheral compartments and tissues through transport mechanisms used by albumin itself, which can affect tissue exposure over time [1].

Does albumin binding change paclitaxel uptake by cells?

Yes. Once paclitaxel is carried in complex with albumin, cells that take up albumin (via albumin transport and uptake processes) can also take up albumin-associated paclitaxel. This creates a link between the drug’s carrier state (albumin-bound) and cellular uptake, which can affect where and how much paclitaxel accumulates inside cells [1].

What happens if albumin levels are low?

Lower circulating albumin can reduce the amount of paclitaxel that can bind to albumin, which can shift the balance toward a larger fraction of paclitaxel that is not albumin-associated. That can change transport and distribution characteristics because the drug’s primary carrier in the body is tied to albumin availability [1]. In clinical settings, low albumin is often treated as a factor that can influence drug handling and overall risk, though exact effects vary by formulation and patient factors [1].

Is this specific to certain paclitaxel formulations?

Albumin’s role is most directly relevant to paclitaxel strategies that rely on albumin-associated transport. Formulations that are designed to deliver paclitaxel in association with albumin are expected to depend more strongly on these binding/transport mechanisms than formulations that do not emphasize albumin association [1].

Bottom line

Albumin helps carry paclitaxel through the bloodstream and supports tissue delivery by binding the drug and linking it to albumin uptake/transport pathways. This makes albumin a key determinant of paclitaxel transport, distribution, and cellular delivery [1].

Sources:
[1] https://www.ncbi.nlm.nih.gov/books/NBK557589/